The Danish national guidelines for treatment of oral squamous cell carcinoma

Anders Bilde, Christian von Buchwald, Jørgen Johansen, Lars Bastholt, Jens A H M Sørensen, Peter Marker Holst, Annelise Krogdahl, Hanne Sand Hansen, Lena Specht, Jørgen Kirkegaard, Elo Verner Andersen, Jens Knud Daugaard Bentzen, Christian Hjort-Sørensen, Lisbeth Juhler Andersen, Bengt Agathon Nielsen, Troels Bundgaard, Marie Overgaard, Cai Grau, Danish Society for Head and Neck Oncology

Research output: Contribution to journalJournal articleResearchpeer-review

32 Citations (Scopus)

Abstract

The treatment strategy for oral squamous cell carcinoma in Denmark has traditionally varied between the different head and neck oncology centres. A study group within the Danish Society for Head and Neck Oncology (DSHHO) was formed with the aim of optimising and standardising the treatment strategy. The approach was to use single modality treatment for stage I, stage II and some stage III and combined modality treatment for stage III and IV. Surgery was the preferred treatment when it was considered possible to perform a radical excision of the tumour and possible lymph node metastases with acceptable aesthetic and functional outcome. The implementation of a recognised national guideline facilitates prospective studies on a large well-characterised cohort. This increases the possibility of obtaining valid data on parameters such as morbidity, loco-regional control and survival. In addition the establishment of a reference program facilitates national monitoring of the treatment using defined indicators and standards.
Original languageEnglish
JournalActa Oncologica
Volume45
Pages (from-to)294-9
Number of pages6
ISSN0284-186X
DOIs
Publication statusPublished - 1 Jan 2006
Externally publishedYes

Keywords

  • Carcinoma, Squamous Cell
  • Denmark
  • Head and Neck Neoplasms
  • Humans
  • Mouth Neoplasms
  • Radiotherapy
  • Societies, Medical

Fingerprint

Dive into the research topics of 'The Danish national guidelines for treatment of oral squamous cell carcinoma'. Together they form a unique fingerprint.

Cite this